EEG
ARIA

E.E. Geduld’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

E.E. Geduld’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.44M Buy
115,900
+5,000
+5% +$60.2K 0.81% 7
2016
Q3 		$1.52M Buy
110,900
+65,800
+146% +$661K 1.51% 9
2016
Q2 		$333K Sell
45,100
-75,000
-62% -$563K 0.44% 42
2016
Q1 		$767K Sell
120,100
-65,000
-35% -$364K 1.05% 13
2015
Q4 		$1.16M Sell
185,100
-25,000
-12% -$164K 0.72% 12
2015
Q3 		$1.23M Sell
210,100
-75,000
-26% -$578K 1.15% 11
2015
Q2 		$2.36M Sell
285,100
-15,000
-5% -$133K 1.47% 6
2015
Q1 		$2.47M Buy
300,100
+7,900
+3% +$58.4K 1.65% 5
2014
Q4 		$2.01M Buy
292,200
+20,000
+7% +$125K 1.08% 8
2014
Q3 		$1.47M Buy
272,200
+27,100
+11% +$158K 1.04% 11
2014
Q2 		$1.56M Sell
245,100
-32,500
-12% -$224K 0.97% 12
2014
Q1 		$2.24M Sell
277,600
-557,500
-67% -$4.34M 1.21% 9
2013
Q4 		$5.7M Buy
+835,100
New +$4.51M 2.75% 3

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

E.E. Geduld's ARIA Position: Q4 2016 in Review

E.E. Geduld increased its Ariad Pharmaceuticals Inc (ARIA) stake by 4.5% in Q4 2016, buying an estimated $60.2K and bringing the position to 115,900 shares worth $1.44M. The position accounts for 0.81% of the portfolio, ranked #7.

E.E. Geduld first reported a position in ARIA in Q4 2013 and has held it in 13 quarters since. The position peaked at $5.7M in Q4 2013. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

  • E.E. Geduld held 115,900 shares of Ariad Pharmaceuticals Inc worth $1.44M as of Q4 2016.
  • E.E. Geduld bought 5,000 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $60.2K.
  • Ariad Pharmaceuticals Inc made up 0.81% of E.E. Geduld's portfolio in Q4 2016, its #7 holding.
  • E.E. Geduld first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and has held it in 13 quarters since.
  • E.E. Geduld's Ariad Pharmaceuticals Inc position peaked at $5.7M in Q4 2013.
  • 200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.